Profusa Secures $200K in Highly Dilutive Equity Line Drawdown with "True-Up" Mechanism
Summary
Profusa, Inc. has initiated a draw-down of up to $200,000 from its existing equity line of credit, agreeing to highly dilutive terms including a significant discount to VWAP and a "true-up" mechanism that issues more shares if the stock price declines further.
Key Events
-
Equity Line Drawdown Initiated
Profusa submitted an Advance Notice to Ascent Partners Fund LLC to purchase shares under an existing equity line of credit arrangement, effective from June 8, 2026, until July 15, 2026.
-
Highly Dilutive Pricing
The purchase price for shares will be 97% of the lowest volume-weighted average price (VWAP) of the common stock over the ten trading days prior to the Advance Notice date.
-
"True-Up" Mechanism Included
A price adjustment mechanism will issue additional shares to Ascent if the actual lowest VWAP during their selling period is lower than the initial closing price, leading to further dilution for existing shareholders.
-
Capital Cap and Immediate Funding
Each Advance Notice is capped at $200,000 or 9.99% of shares outstanding. Ascent will fund the purchase upon delivery of shares, providing immediate cash to Profusa.
Analysis
This filing details Profusa's latest attempt to secure capital through a highly dilutive equity line of credit. The terms, which include a purchase price at 97% of the lowest 10-day VWAP and a "true-up" mechanism that issues additional shares if the stock price falls further, indicate the company's desperate need for funds. This financing structure is particularly detrimental to existing shareholders as it guarantees further dilution, especially in a declining stock environment, and is consistent with the company's ongoing financial distress, including delisting threats and a going concern warning.
At the time of this filing, PFSA was trading at $0.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $0.26 to $957.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.